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Abstract
Objectives: Measles is a highly infectious immunizable disease with 
potential for eradication but is still responsible for high mortality 
among children, particularly in developing nations like Nigeria. This 
study aims to determine the hospital based prevalence of measles, 
describe the vaccination status of children managed for measles at 
the Federal Medical Centre, Bida, Niger state and to identify the 
parental disposition to measles vaccination. 
Methods: This is a cross-sectional study carried out over a period of 
18 months beginning from July 2007. All children with a diagnosis 
of measles made clinically and reinforced with serological test in the 
WHO Measles, Rubella and Yellow Fever laboratory in Maitama 
District  Hospital,  Abuja  were  recruited.  Informed  consent  was 
obtained  from  the  parents/care  givers.  Structured  questionnaire 
was used to obtain information and data analysis was by SPSS 
version 15.
Results: One hundred and nine children were managed for measles, 
constituting 8% of total admission over the study period. The male 
to female ratio was 1.2:1. Of the 109 children with measles, 90 
(82%) did not receive measles vaccination. Eighty-eight (80%) of 
the parents or guardian felt vaccination was bad for various reasons. 
Of  the  23  (21.1%)  children  whose  parents  or  guardians  were 
positively disposed to vaccination, one death was recorded while 
the remaining seven deaths were recorded among children whose 
parents were negatively disposed to vaccination. All the deaths were 
in the non-vaccinated group below 2 years of age.
Conclusion:  Measles  is  still  a  major  health  burden  in  our 
community. The majority of affected children were not vaccinated 
due to negative parental disposition. Continuous health education 
is  required  for  change  the  disposition  of  the  parents/guardian 
and improve vaccination coverage to minimize measles associated 
morbidity and mortality.
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Introduction
Measles is an old disease; old enough to merit being referred 
to as the First disease.1 Since its emergence thousands of years 
ago, it has caused millions of deaths largely due to an increased 
susceptibility of measles infected persons to secondary bacterial and 
other viral infections. This period of increased susceptibility lasts 
for several weeks to months after the onset of measles rash,2 and is 
attributed to a prolonged state of immune suppression commonly 
referred to as post measles anergy. Most deaths associated with 
measles are due to secondary bacterial pneumonia.3 Immunization 
consequent  upon  effective  vaccination  has  been  successful  in 
many developed nations such as Canada and United Kingdom. In 
Canada, sustained transmission has been eliminated by the current 
schedule and high vaccine coverage. However, imported cases still 
occur though secondary spread from these imported cases is self-
limited and involves the few Canadians in the isolated groups that 
are philosophically opposed to immunization. The secondary spread 
to the general population is very limited.4-5 
Measles is a highly infectious immunizable disease with potential 
for eradication but is still responsible for high mortality among 
children particularly in developing nations like Nigeria. Currently, 
Nigeria is one of the 47 countries in the world where the burden of 
measles is highest and where it is still responsible for the highest 
number of vaccine preventable death. The current national measles 
vaccination coverage is 62% with a very wide variation in the country 
that has once achieved coverage of 80% with routine immunization. 
The disposition of parents or guardians of the Nigerian children is 
however key to improved vaccination coverage, and by extension to 
significant reduction in the morbidity and mortality associated with 
measles. The lack of data on measles in Bida, Niger state of Nigeria 
necessitated the study. 
In the United Kingdom by 1995, uptake of measles, mumps, and 
rubella vaccination exceeded 90%. Increasing vaccination coverage 
was mirrored by a fall in notifications from around half a million 
cases annually in the 1960s and culminated in the interruption of 
endemic measles transmission.4x
This is not yet so in several developing nations such as Nigeria. 
In Nigeria, the routine immunization program which was started 
in 1979 as an initiative of World Health Organization (WHO) 
Expanded program on Immunization (EPI). It targets childhood Oman Medical Specialty Board
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killer diseases such as Tuberculosis, Diphtheria, Pertusis, Tetanus, 
Poliomyelitis  and  Measles.  In  Nigeria,  EPI  was  upgraded  to 
National Program on Immunization (NPI) in 1997 to demonstrate 
the  commitment  of  the  country  and  additional  vaccines  against 
Hepatitis B and Yellow fever were introduced.5
Recently, there have been increased activities by various health 
regulatory bodies in the control of measles throughout the world, 
Nigeria inclusive.5,6 As part of this demonstration of commitment 
by the Federal Government of Nigeria and Niger State ministry 
of health in the prevention and treatment of measles collaborated 
with WHO and national and sub-national laboratories were set 
up in strategic places.7 In Nigeria, one such laboratory is located 
at  Maitama  District  Hospital,  Abuja.  Serologic  kits  were  used 
for  laboratory  confirmation  of  measles  according  to  the WHO 
standards.
With  all  these  in  place,  a  need  to  determine  the  current 
prevalence, vaccination status of measles infected children and its 
immediate outcome became important. Furthermore there is the 
need to establish relevant data which are lacking on measles in the 
Federal Medical Centre, Bida, the largest referral health centre and 
the only tertiary hospital in the Niger state, Nigeria.
Methods
All children admitted over a period of 18 month beginning from 
July 2007 with measles were studied at the Federal Medical Centre, 
Bida,  Niger  State.  Informed  consent  was  obtained  from  their 
parents or care givers. Structured questionnaire was used to obtain 
information  on  age,  gender,  main  symptoms,  duration,  and  the 
vaccination status as regards the routine NPI of children presenting 
with  measles  from  their  parents  or  guardians.  Information  on 
disposition of parents or guardians of measles infected children 
to measles vaccination was also sought. The duration of admission 
for admitted children with measles infection and the immediate 
outcome were similarly documented.
Measles was clinically diagnosed by presence of fever, maculo-
papular  (non-vesicular)  generalized  rash  and  cough,  coryza  or 
conjunctivitis. Blood samples from children diagnosed with measles 
were pooled and sent to the WHO Measles, Rubella and Yellow 
fever laboratory in District Hospital, Maitama, Abuja on regular 
basis by health officers from the Niger state ministry of Health. 
ELISA technique was used in detecting measles IgM according 
to  WHO  standard.8  Components  of  a  specimen  collection  kit 
supplied by the WHO for measles diagnosis have been specified 
and  are  suitable  for  distributing  to  facilities  collecting  samples 
from suspected measles subjects. The basic kit for blood collection 
consisted  of  5  ml  vacutainer  tube  (non-heparinized)  with  23  g 
needle, tourniquet, sterilizing swabs, serum storage vials, specimen 
labels, band aid, ziplock plastic bags, specimen referral form, and 
cold box with ice packs. Data analysis was done with SPSS version 
15. All patients were offered the standard care and counseling as 
required.
Results 
A total of 1,364 children were admitted over the 18 months study 
period at the Federal Medical Centre, Bida. One hundred and nine 
(8.0%) of them had measles and their ages ranged from 6 months to 
6 years. The age distribution of all the managed children is as shown 
in Table 1, with 22 (20.2%) infants, 84 (48.8%) under-fives (1-4 
years), 3 (2.8%) children aged 6-11 years, and none (0%) above 12 
years was managed for measles.
Table 1: Age distribution of all children managed over the study 
period
Age group (years) Measles (%) Total 
Less than 1 (Infancy) 22 (20.2) 557
1-5 (Under-five) 84 (77.1) 665
6-12 (school age) 3 (2.7) 90
Over 12 (Adolescent) 0 (0) 52
Total  109 (100) 1,364
The male to female ratio of measles children was 1.2:1. Ninety 
(82.6%) children did not receive measles vaccination. Fifty (55.6%) 
of the children without measles vaccination did not receive any 
other vaccines meant for routine childhood immunization in the 
Nigerian  NPI  schedule.  Nineteen  children  (17.4%)  were  fully 
vaccinated according to the NPI schedule. Of the 19 that were fully 
immunized, 12 were males and 7 were females (χ2 =0.76, p =0.38).
Eighty-eight  (80.7%)  of  the  parents  or  guardians  felt 
immunization  was  bad  for  various  reasons  ranging  from  future 
sterility  (33),  disease  causation  (25),  will  of  the  father  (40),  to 
causing paralysis (15), excessive crying (30) and delayed walking 
(6), Cannot explain (6)  as shown in Fig. 1. Of the 23 children 
whose parents felt immunization was good for their protection, one 
death was recorded while the remaining seven deaths were recorded 
among children whose parents felt immunization was bad for one 
reason  or  the  other.  This  difference  was  statistically  significant 
(Yate's corrected <chi>2 = 13.21, p<0.001). 
Figure 1: Monthly distribution of Measles over the study periodOman Medical Specialty Board
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All  the  measles  associated  mortality  occurred  among  the 
children without measles vaccination and they were among children 
with age 48 months and below. Overall, 99 children were successfully 
managed and discharged, eight died (5 males and 3 females) putting 
the  case  fatality  at  7.3%,  and  two  left  against  medical  advice. 
Monthly distribution of cases was grouped in a quarterly manner, 
(Table 2). Thirteen (11.9%) of the 109 cases occurred during the 
rainy seasons.
Table 2: Quarterly distribution of Cases of measles over the study 
period.
Quarter Frequency (%)
July –September 2007 5 (4.6)
October-December 2007 21 (19.3)
January –March 2008 33 (30.3)
April – June 2008 3 (2.7)
July –September 2008 5 (4.6)
October-December 2008 42 (38.5)
Total  109 (100)
Discussion
The hospital based prevalence of measles in Bida, to our knowledge, 
has not been documented before this study. Even though the study 
was hospital based, it gave an insight as to what may be obtainable 
in the community. Children below the age of 5 years accounted for 
the majority of the morbidity and those below 2 years accounted for 
most of the mortality in this study. This emphasizes the age-groups 
most prone to the infection. Previous studies have shown the latter 
to be the most vulnerable and hence the need for booster doses 
or supplementary immunization as it is being done on National 
Immunization  Days  (NIDs)  even  after  the  routine  vaccinations 
have been completely effected.6,9,10
The study also showed measles mortality to be slightly higher in 
boys in contrast to the findings in Europe where data had suggested 
that measles mortality may be higher in girls by 5%.11 This finding 
may be due to preferential presentation of a male child for medical 
attention  in  this  environment  as  this  is  an  already  established 
culture due to general male preference of the family though, not 
being statistically significant portends that it is no longer a major 
occurrence.12,13
Vaccination coverage of measles containing vaccine (MCV) in 
Nigeria according to WHO/UNICEF is currently put at 62%.5 
This study revealed a hospital based coverage rate of less than 20%. 
This is probably due to the fact that those who asked about their 
vaccination status were those with measles and not the generality 
of the patients admitted. The gender similarity in terms of the 
vaccination status may be due to increased activities of gender equity 
globally, which is the focus of the third millennium development 
goal and this is a good development in a country where preferential 
treatment  of  male  children  has  been  documented  in  previous 
studies.12,13
The various reasons given for non-acceptance of vaccination 
against measles are similar to those for other vaccines at one point 
or the other, and these have been documented by Health regulatory 
consultants.14 The measles case fatality ratio of 7.3% from this study 
is comparable to the findings in Sub-Saharan Africa as a whole , 
where the measles case fatality ratio has been put at 5-10%.6,15 This 
contrasts sharply with the findings from Osogbo where Adetunji 
et al. reported a 19% case fatality.16 This may be a reflection of the 
outlook in a bigger referral hospital with higher utilization, hence 
more cases of severe measles.
In spite of several efforts at immunizing every eligible child 
against measles, the overwhelming majority of children managed 
for measles were not immunized largely due to negative parental 
disposition to immunization programs in the locality of the study. 
This is however, likely to be a product of many factors; of which 
ignorance, or lack of the correct knowledge of vaccination has been 
documented.14  It  therefore  becomes  imperative  to  create  public 
awareness on the efficacy of vaccines with regards to the prevention 
of  measles  mortality  in  view  of  the  fact  that  should  vaccinated 
children  develop  measles  after  exposure,  they  have  less  severe 
disease and significantly lower mortality rates.9,10,15 
Vaccination  programs  increase  the  average  age  of  infection, 
thereby shifts the burden of disease out of the age group with the 
highest case fatality-infancy, and young children.
Remarkable  progress  in  reducing  measles  incidence  and 
mortality has been made in some parts of Sub-Saharan Africa as a 
consequence of increasing measles vaccine coverage, provision of a 
second opportunity for measles vaccination through supplementary 
immunization activities, improved case management, and enhanced 
surveillance with laboratory confirmation of measles cases.9 These 
can only be introduced after ignorance or grave misconceptions 
have been reduced to the barest minimum if not eradicated among 
the populace. Sustained efforts to maintain high coverage rates of 
the  routine  first  dose  of  measles  vaccine,  coupled  with  periodic 
opportunities  for  a  second  dose,  will  achieve  the  level  of  herd 
immunity required to avert the unacceptably high morbidity and 
mortality rates that result from measles epidemics in susceptible 
populations.15,17 This is in view of the fact that studies have shown 
that about four in five children develop protective antibody levels 
when the measles vaccine is administered at nine months of age, and 
nearly all have a protective antibody response after vaccination at 12 
months of age.18,19 Monthly distribution showed higher frequencies 
during the dry seasons. This is in keeping with previous observations 
by earlier studies.1,2,20,21
Conclusion
The hospital based prevalence of measles in Bida was 8.0%, and the 
case fatality was 7.3%. Most of the children managed for measles 
did  not  receive  measles  vaccination.  Four  out  of  five  parents/
caregiver felt immunization was bad for one reasons or the other. 
In view of these cases, to further reduce death caused by measles, 
community approach should be embraced to change the orientation Oman Medical Specialty Board
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of the parents and the care givers of these children who are not able 
to make a choice between "to receive" or "not to receive" vaccination 
for  childhood  killer  diseases,  measles  inclusive.  The  lack  of 
immunization and negative parental disposition are the major risks 
of death among children afflicted by measles.
We recommend that there should be more awareness about 
the  gains  of  immunization  for  the  children  of  Bida  and  their 
parents should be counseled to always present them for routine 
immunization  and  the  supplementary  immunization  while 
correcting their wrong ideas about the procedure. Female education 
should also be pursued as a well informed woman will be able to 
convince the man when the need arises.
Acknowledgements 
We thank the parents and the children who willingly took part 
in the study. Also, special appreciation to Mr. Audu Daudu and 
Mohammed Naibi both from the Niger state ministry of health. 
They  provided  the  needed  support,  took  the  specimen  to  the 
National WHO Measles, Rubella and Yellow fever laboratory in 
Maitama District Hospital, Abuja and brought the results back. 
Also, we thank Mr. Suan Thomas, the chief Technologist and the 
focal person in charge of the laboratory for the cooperation we had 
from him and other members of staff at the laboratory.
References
1.  Hart  CA,  Bennett  M,  Begon  ME.  Zoonoses.  J  Epidemiol  Community 
Health 1999 Sep;53(9):514-515.
2.  Akramuzzaman  SM,  Cutts  FT,  Wheeler  JG,  Hossain  MJ.  Increased 
childhood morbidity after measles is short-term in urban Bangladesh. Am J 
Epidemiol 2000 Apr;151(7):723-735. 
3.  Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet 2003 
Mar;361(9359):763-773. 
4.  Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it 
by 2010? BMJ 2006 Oct;333(7574):890-895. 
5.  WHO/UNICEF Review of National Immunization Coverage 1980-2008 
;July, 2009:2-10.
6.  World Health Organization. Progress in global measles control and mortality 
reduction, 2000-2007. Wkly Epidemiol Rec 2008 Dec;83(49):441-448. 
7.  World Health Organization. Role and function of the laboratory in measles 
control and elimination In: Manual for the laboratory diagnosis of measles 
virus infection December 1999. WHO/V&B/00.16: 14-22.
8.  World Health Organization. ELISA tests for measles antibodies: principles 
and  protocols.  In:  Manual  for  the  laboratory  diagnosis  of  measles  virus 
infection December 1999. WHO/V&B/00.16: 33-38.
9.  Otten M, Kezaala R, Fall A, Masresha B, Martin R, Cairns L, et al. Public-
health impact of accelerated measles control in the WHO African Region 
2000-03. Lancet 2005 Sep;366(9488):832-839. 
10.  Mbabazi WB, Nanyunja M, Makumbi I, Braka F, Baliraine FN, Kisakye 
A,  et  al.  Achieving  measles  control:  lessons  from  the  2002-06  measles 
control strategy for Uganda. Health Policy Plan 2009 Jul;24(4):261-269. 
doi:10.1093/heapol/czp008. 
11.  Garenne  M.  Sex  differences  in  measles  mortality:  a  world  review.  Int  J 
Epidemiol 1994 Jun;23(3):632-642. 
12.  Yahaya  AL.  Women  empowerment  in  Nigeria:  problems,  prospects  and 
implications for counseling. The Counsellor 1999;17(1):132-137.
13.  Ezeigbo A. Gender issues in Nigeria: a feminine perspective. Lagos: Vista 
books ltd 1996; 15-20.
14.  FBA Health System Analysts. State of routine immunization services in 
Nigeria and reasons for current problems. June 2005: 7-10.<
15.  Strebel  PM,  Cochi  SL.  Waving  goodbye  to  measles.  Nature  2001 
Dec;414(6865):695-696. 
16.  Adetunji OO, Olusola EP, Ferdinad FF, Olorunyomi OS, Idowu JV, Ademola 
OG. Measles Among Hospitalized Nigerian Children. The Internet Journal 
of Pediatrics and Neonatology 2007;7:1-6.
17.  van den Ent M, Gupta SK, Hoekstra E. Two doses of measles vaccine reduce 
measles dealths. Indian Pediatr 2009 Nov;46(11):933-938. 
18.  Enquselassie F, Ayele W, Dejene A, Messele T, Abebe A, Cutts FT, et al. 
Seroepidemiology  of  measles  in  Addis  Ababa,  Ethiopia:  implications  for 
control through vaccination. Epidemiol Infect 2003 Jun;130(3):507-519. 
19.  Adu FD, Akinwolere OAO, Tomori 0, Uche LN. Low seroconversion rates 
to measles vaccine among children in Nigeria. WHO Bulletin 1992; 70 (4): 
457 -4 37. 460.
20.  Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A, Nargaye KD, et al. 
Unacceptably high mortality related to measles epidemics in Niger, Nigeria, 
and Chad. PLoS Med 2007 Jan;4(1):e16. d
21.  Centers for Disease Control and Prevention (CDC). Vaccine preventable 
deaths  and  the  global  immunization  vision  and  strategy,  2006-2015. 
MMWR Morb Mortal Wkly Rep 2006 May;55(18):511-515. 
       